Sofosbuvir/Velpatasvir

Treatment for Acute hepatitis C

Effectiveness
98%
Safety Score
70%
Clinical Trials
1
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
0
Sofosbuvir/Velpatasvir Outcomes

for Acute hepatitis C

Efficacy Outcomes
Overall Effectiveness
+98%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Sofosbuvir/Velpatasvir in Acute hepatitis C

Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir

NCT03818308COMPLETEDPHASE2
View Study
20 participants
INTERVENTIONAL
Berlin, Germany +13 more
Started: May 28, 2019